Pathogenesis and Surgical Treatment of Congenitally Corrected Transposition of the Great Arteries (ccTGA): Part III

Marek Zubrzycki1, Rene Schramm2, Angelika Costard-Jäckle2

  • 1Department of Surgery for Congenital Heart Defects, Heart and Diabetes Center NRW, University Hospital, Ruhr-University Bochum Georgstr. 11, 32545 Bad Oeynhausen, Germany.

Journal of Clinical Medicine
|September 28, 2024
PubMed

Insights

Congenitally corrected transposition of the great arteries (ccTGA) is a rare heart defect where blood flows correctly despite abnormal anatomy. Surgical repair aims to restore normal function and improve long-term survival.

Area of Science:

  • Cardiology
  • Pediatric Cardiology
  • Congenital Heart Disease

Background:

  • Congenitally corrected transposition of the great arteries (ccTGA) is a rare congenital heart defect (0.5% of all CHDs).
  • It involves both atrioventricular and ventriculoarterial discordance, leading to a physiologically normal but anatomically complex circulation.
  • Untreated ccTGA often results in systemic right ventricle failure, tricuspid regurgitation, arrhythmias, and high early mortality.

Purpose of the Study:

  • To review the complex anatomy and pathophysiology of ccTGA.
  • To discuss current surgical repair strategies for ccTGA.
  • To highlight the importance of anatomic repair for long-term patient survival.

Main Methods:

  • Review of existing literature on ccTGA.
  • Analysis of surgical techniques including double-switch, Rastelli procedure, and aortic root translocation variations (Nikaidoh, half-turned truncal switch).
  • Evaluation of outcomes associated with different repair strategies.

Main Results:

  • ccTGA requires intervention in most cases, with options including physiological repair, anatomical repair, or univentricular palliation.
  • Anatomical repairs aim to restore the left ventricle as the systemic ventricle.
  • Advanced techniques like Nikaidoh and en bloc rotation improve left ventricular outflow tract geometry.

Conclusions:

  • Anatomical repair of ccTGA is crucial for enabling patients to survive into adulthood.
  • Modern surgical approaches offer improved outcomes and address complexities like left ventricular outflow tract obstruction.
  • Continued advancements in surgical techniques are vital for managing this complex congenital heart defect.

Related Concept Videos

Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
3
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
3
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
341